Expression of the multidrug transporter P-glycoprotein is highly correlated with clinical outcome in childhood acute lymphoblastic leukemia: Results of a long-term prospective study

Leukemia and Lymphoma

Volumn 43, Issue 2, 2002, Pages 309-314

  Dhooge, Catharina ^a   De Moerloose, Barbara ^a   Laureys, Geneviève ^a   Ferster, Alice ^b   De Bacquer, Dirk ^a   Philippe, Jan ^a   Leroy, Jules ^a   Benoit, Yves ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Department of Pediatrics Reine Fabiola ^*  (Belgium)

Author keywords

Childhood leukemia; Immunocytochemistry; Multidrug resistance; P glycoprotein

Indexed keywords

ANTHRACYCLINE; CARRIER PROTEIN; CORTICOSTEROID; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BLAST CELL; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INFANT; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LONGITUDINAL STUDIES; MALE; MATCHED-PAIR ANALYSIS; P-GLYCOPROTEIN; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0036193019     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190290006080     Document Type: Article

References (18)

1. "Acute lymphoblastic leukemia"
2. "Multidrug resistance in malignancies of children"
3. "Multidrug resistance in cancer"
4. "Molecular mechanisms of drug resistance in tumours"
5. "Pharmacological considerations in the modulation of multidrug resistance"
6. "Expression of the multidrug resistance-associated P-glycoprotein (P-GP) in 59 cases of de novo acute lymphoblastic leukemia: Prognostic implications"
7. "P-glycoprotein and gluthathione-S-transferase II in childhood acute lymphoblastic leukaemia"
8. "P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: Results of a 6-year prospective study"
9. "Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase II gene expression in primary and relapsed state adult and childhood leukaemias"
10. "Expression of mdr1, topoisomerase IIα/β, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias"
11. "Correlation of P-glycoprotein expression and function in childhood acute leukemia: A children's cancer group study"
12. "Relationship between major vault protein/lung resistance protein. Multidrug resistance-associated protein, P-glycoprotein expression and drug resistance in childhood leukemia"
13. "Abschatzung der tumorzellmasse bei der akuten lymphoblastischen leukamie im kindersalter: Prognostische bedeutung und praktische anwendung"
14. "Expression of the multidrug transporter. P-glycoprotein, in childhood leukemia: A prospective clinical study"
15. "Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: Consensus recommendations"
16. "French multicentric evaluation of mdr1 gene expression by RT-PCR in leukemia and solid tumours. Standardization of RT-PCR and preliminary comparisons between RT-PCR and immunohistochemistry in solid tumours"
17. "Prognostic value of rhodamine-efflux and MDR-1/P-170 expression in childhood acute leukemia"
18. "Expression of PKC isoenzyme and MDR-associated genes in primary and relapsed state AML"